Abstract
Purpose:
To report a case of sixth nerve palsy after intravitreal bevacuzimab injection.
Methods:
After intravitreal bevacizumab injection in a 64-year-old man, the patient admitted to our clinic with the complaint of diplopia. A complete ophthalmologic examination was done to clear the symptomatology of patient.
Results:
Examination of ductions revealed marked limitation of abduction of the right eye and full ductions of the left eye, consistent with right lateral rectus paralysis.
Conclusions:
Although intravitreal bevacizumab injections are generally well tolerated, it is possible that some serious systemic adverse events may occur. For this reason, patients must be closely monitored following these injections.
MeSH terms
-
Abducens Nerve Diseases / chemically induced*
-
Abducens Nerve Diseases / physiopathology
-
Angiogenesis Inhibitors / administration & dosage*
-
Angiogenesis Inhibitors / adverse effects*
-
Antibodies, Monoclonal / administration & dosage*
-
Antibodies, Monoclonal / adverse effects*
-
Antibodies, Monoclonal, Humanized
-
Bevacizumab
-
Choroidal Neovascularization / diagnosis*
-
Choroidal Neovascularization / etiology
-
Diabetes Mellitus, Type 2 / complications
-
Esotropia / chemically induced
-
Esotropia / physiopathology
-
Fluorescein Angiography
-
Follow-Up Studies
-
Fundus Oculi
-
Humans
-
Injections, Intraocular
-
Macular Degeneration / complications*
-
Male
-
Middle Aged
-
Remission, Spontaneous
-
Vascular Endothelial Growth Factor A / antagonists & inhibitors
-
Vitreous Body
Substances
-
Angiogenesis Inhibitors
-
Antibodies, Monoclonal
-
Antibodies, Monoclonal, Humanized
-
Vascular Endothelial Growth Factor A
-
Bevacizumab